Trials / Conditions / Non-small Cell Lung Adenocarcinoma
Non-small Cell Lung Adenocarcinoma
3 registered clinical trials studyying Non-small Cell Lung Adenocarcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers NCT05873686 | Nuvectis Pharma, Inc. | Phase 1 |
| Active Not Recruiting | A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and NCT05943795 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 3 |
| Terminated | A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced N NCT01798485 | Synta Pharmaceuticals Corp. | Phase 3 |